Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Diprofos*


Contraindicated

Contraindicated
Diprofos* :
Type Medicine Non Marketed
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory MSD
Responsible Party Schering-Plough Labo NV Co subsidiary of Schering-Plough Corporation, USA
Origin Belgium
Manufacturer Schering Plough Labo NV
Origin Belgium
ATC H02AB01

Your comment will appear shortly after approval

Diprofos* :

Revision Date : 01/07/2016


Effect Frequency
Abdominal distension Not known
Abscess sterile Not known
Alkalosis hypokalaemic Not known
Allergic reaction Not known
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arthritis Charcot-type Not known
Aseptic necrosis of head and neck of femur Not known
Blindness Rare
Bone pain Not known
Carbohydrate tolerance decreased Not known
Cephalea Not known
Congestive heart failure Not known
Convulsion Not known
Cushing's syndrome Not known
Depression Not known
Dermatitis allergic Not known
Diabetes mellitus Not known
Ecchymosis Not known
Erythema facial Not known
Euphoria Not known
Exophthalmos (Bulging eyes) Not known
Foetal growth restriction Not known
Fracture vertebral Not known
Gastric haemorrhage Not known
Gastric perforation Not known
Gastric ulcer Not known
Glaucoma Not known
Growth retardation Not known
Headache Not known
Hypertension Not known
Hypotension Not known
Immune disorders NEC Not known
Increased insulin requirement Not known
Insomnia Not known
Intestinal perforation Not known
Irritability Not known
Joint injury Not known
Lipomatosis Not known
Menstrual disorder Not known
Mood disorders Not known
Muscle atrophy Not known
Muscle weakness Not known
Myasthenia gravis aggravated Not known
Nausea Not known
Nitrogen balance negative Not known
Oesophagitis ulcerative Not known
Osteoporosis Not known
Pancreatitis Not known
Pathological fracture Not known
Personality change Not known
Petechiae Not known
Posterior subcapsular cataract Not known
Potassium deficiency Not known
Pseudo-tumor cerebri Not known
Psychotic reactions Not known
Shock Not known
Skin atrophy Not known
Skin hyperpigmentation Not known
Skin hypopigmentation Not known
Skin test negative ( Not known
Sodium retention Not known
Spontaneous fracture Not known
Steroid myopathy Not known
Sweating increased (Excessive sweating) (Hyperhydrosis) Not known
Tendon rupture Not known
Urticaria Not known
Vertigo Not known
Vomiting Not known
Water retention Not known
Weight increased (weight gain) Not known
Wound healing delayed Not known

Different Units By MoH Code

Revision Date : 01/03/2018

Diprofos*  MoH 2443 :
Form Suspension for injection
Packaging Ampoules
Package Size 1x2ml
Strength 5mg/2mg/ml
Storage Condition 2-25°C protect from light
NSSF ✘
Quarantine ✘
Reg. Number 26519
Submission date 01/01/1988
Registration Year 1988
Archived Date 2018


NB : Change of agent in 2007 from Kettaneh Pharma to Abela Freres

Price Comparison

● Country: Abu Dhabi
● Package Size: 1x2ml
● Public Price: 27 AED ( 652,347.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 27 AED ( 652,347.00 LBP )
● Pharmacy Price: 21.82 AED ( 527193.02 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 2ml Ampoule
● Public Price: 27 AED ( 652,347.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 27 AED ( 652,347.00 LBP )
● Pharmacy Price: 21.82 AED ( 527193.02 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 1x2ml
● Public Price: 4.5 EUR ( 435,942.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 4,5 EUR ( 387,504.00 LBP )
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 2ml
● Public Price: 16.9 SAR ( 399,516.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 16,9 SAR ( 378,240.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 1x2ml
● Public Price: 3.75 JOD ( 469,578.75 LBP )
● Pack size unit used: 1
● Cost/Unit: 3,75 JOD ( 375,663.00 LBP )
● Pharmacy Price: 2.86 JOD ( 358132.06 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 2ml Amp.
● Public Price: 14 QAR ( 343,812.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 14 QAR ( 343,812.00 LBP )
● Pharmacy Price: 11.101491466 QAR ( 272630.42742203 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 1x2ml
● Public Price: 1.3 BHD ( 309,054.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 1,3 BHD ( 237,734.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1x2ml
● Public Price: 1.42 OMR ( 327,642.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 1,42 OMR ( 230,734.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 5
● Public Price: 286.44 CZK ( 1,093,914.36 LBP )
● Pack size unit used: 5
● Cost/Unit: 57,288 CZK ( 217,683.00 LBP )
● Exfactory Price: 191.28 CZK
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1x2ml
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Non Marketed

● Country: Belgium
● Package Size: 1
● Medica Comments: Not available in the country of origin
● Reference: cbip
● Pricing Date: 14/10/2019
● Type: Medicine not available

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info